Atlas Trials

A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors

Clinical trial NCT02322853 · TERMINATED

Trial details

NCT number
NCT02322853
Sponsor
Centre Francois Baclesse
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
PostmenopausalMetastatic Breast Cancer
Start date
2015-01-01
Primary completion
2017-04-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.